After Ramdev launched COVID-19 ‘medicine’, complaint filed against yoga guru in Bihar court
Muzaffarpur (TN): A criminal complaint was on Tuesday registered against yoga guru Ramdev and Patanjali Ayurved MD Acharya Balkrishna in a Bihar court, hours after the duo launched what they claimed to be a medicine to treat coronavirus.
The complaint sought filing of an FIR on criminal conspiracy, cheating, and other charges against Ramdev and Acharya Balkrishna.
The complaint was lodged in the court of Chief Judicial Magistrate Mukesh Kumar by Tamanna Hashmi, who identifies himself as a social worker. Hearing in the matter is on June 30.
Hashmi has named Patanjali Research Institute convenor Ramdev and his aide Balkrishna, the chairman of the organisation, as accused. The complainant said the “Coronil tablet” launched by the duo to cure COVID-19 is nothing but misleading.
It was also noted in the complaint that the Ayush Ministry has asked Patanjali Ayurved Ltd to stop publicising or advertising its claims regarding the medicine till the issue is “duly examined”.
The ministry further said that the “facts of the claim and details of the stated scientific study are not known to the Ministry”.
Hashmi seeks registration of a case under Sections 420 (cheating and dishonesty inducing delivery of property), 120B (criminal conspiracy) and 270 (malignant act likely to spread infection of disease dangerous to life) of the Indian Penal Code.
Ramdev had yesterday launched Patanjali’s Coronil tablet, claiming that it could cure the highly contagious disease within seven days. While mentioning about the clinical trials, Ramdev had said, “Under this, 280 patients were included and 100 per cent of those recovered.” The yoga guru even said that 69 per cent of the patients had recovered within three days.
Hours later, the Ayush Ministry stated: “In order to make this Ministry aware of the facts of the aforesaid news and verify the claims, Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for Covid-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined.”